Clinical Trials for Castrate Resistant Prostate Cancer

Find clinical trials for castrate resistant prostate cancer. Discover research opportunities and treatment options in your area.

9 Active Trials Found

Showing 9 trials on this page

Page 1 of 1

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT ID: NCT06999187

This clinical trial is looking at a new treatment called DR-0202 for patients with certain types of advanced cancers, including triple-negative breast cancer and non-small cell lung cancer, among o...

Recruiting

Phase: PHASE1 Type: interventional Locations: Fairfax, Virginia, United States, Denver, Colorado, United States +8 more

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

NCT ID: NCT06395519

This clinical trial is studying a new medication called ETX-19477, which targets a specific enzyme involved in cancer growth. Researchers want to find out how safe the drug is, how the body process...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Boston, Massachusetts, United States +11 more

TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors

NCT ID: NCT04969315

This clinical trial is investigating two new treatments, called TT-10 and TT-4, both alone and in combination, for patients with advanced solid tumors like kidney cancer, prostate cancer, lung canc...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Louisville, Kentucky, United States +7 more

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

NCT ID: NCT05766371

This clinical trial is investigating a combination treatment for men with metastatic castration-resistant prostate cancer (mCRPC), which is a type of prostate cancer that continues to grow despite ...

Recruiting

Phase: PHASE2 Type: interventional Locations: San Francisco, California, United States

Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer

NCT ID: NCT06527690

This clinical trial is looking at how effective a combination of three medications—Niraparib, Abiraterone Acetate, and Prednisone—works in treating a specific type of prostate cancer called metasta...

Not yet recruiting

Phase: PHASE2 Type: interventional

Clinical Outcomes of Use of Olaparib in Castration Resistant Prostate Cancer

NCT ID: NCT06783127

This clinical trial is studying the effects of a medication called olaparib on men with a specific type of prostate cancer known as metastatic castration-resistant prostate cancer (mCRPC). The goal...

Recruiting

Type: observational Locations: Napoli, Italy, Trento, Italy

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

NCT ID: NCT05488548

This clinical trial is studying a new treatment called EP31670, which is designed to help patients with certain advanced cancers, including castrate-resistant prostate cancer, NUT carcinoma, chroni...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Boston, Massachusetts, United States +4 more

Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage

NCT ID: NCT05627752

This clinical trial is studying the effects of a combination of two cancer treatments, docetaxel and enzalutamide, in men who have advanced prostate cancer that has become resistant to hormonal the...

Recruiting

Phase: PHASE2 Type: interventional Locations: Wuhan, Hubei, China

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

NCT ID: NCT05415098

This clinical trial is studying a new medication called APG-5918 to see how safe it is and how well it works for patients with advanced solid tumors or certain types of lymphomas, including nasopha...

Recruiting

Phase: PHASE1 Type: interventional Locations: New Haven, Connecticut, United States, Springdale, Arkansas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions